Document is current
Any future updates will be listed below
-
Authors
Nakaigawa, Noboru
Tomita, Yoshihiko
Tamada, Satoshi
Tatsugami, Katsunori
Osawa, Takahiro
Oya, Mototsugu
Kanayama, Hiroomi
Miura, Yuji
Sassa, Naoto
Nishimura, Kazuo
Nozawa, Masahiro
Masumori, Naoya
Miyoshi, Yasuhide
Kuroda, Shingo
Kimura, Akiko https://orcid.org/0000-0001-8136-5009
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03339219 at ClinicalTrials.govDocuments that mention this clinical trial
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma
https://doi.org/10.1007/s10147-022-02283-w
- License Information
-
More Information
Article History
Received: 19 September 2022
Accepted: 15 December 2022
First Online: 3 January 2023
Declarations
:
: Noboru Nakaigawa: Honoraria from Biopharma, BMS, Merck, MSD, Ono Pharmaceutical, Pfizer and Takeda. Yoshihiko Tomita: Research grants from Astellas, Ono Pharmaceutical and Takeda; and honoraria from Astellas, BMS, Ono Pharmaceutical and Pfizer. Satoshi Tamada: Honoraria from Merck Biopharma, MSD, Pfizer and Takeda. Katsunori Tatsugami: Honoraria from BMS, Merck Biopharma, MSD, Ono Pharmaceutical, Pfizer and Takeda. Takahiro Osawa: Honoraria from Takeda. Mototsugu Oya: Honoraria from Bayer, Bristol-Myers Squibb, Eisai, Merck, MSD, Novartis, Ono, Pfizer, and Takeda; scholarship donations from Bayer, Ono Pharmaceutical and Takeda. Hiroomi Kanayama: No conflict of interest to disclose. Yuji Miura: Research funding from MSD, Ono Pharmaceutical; and honoraria from Bristol-Myers Squibb, Eisai, and Takeda. Naoto Sassa: No conflict of interest to disclose. Kazuo Nishimura: Honoraria from Merck Biopharma. Masahiro Nozawa: Honoraria from Takeda. Naoya Masumori: Research funding from Astellas, Bristol Myers Squibb and MSD; honoraria from Astellas, Astrazeneca, Bayer, Janssen, Kissei and Takeda. Yasuhide Miyoshi: No conflict of interest to disclose. Shingo Kuroda: An employee and stock owner of Takeda Pharmaceutical Company Limited. Akiko Kimura: An employee of Takeda Pharmaceutical Company Limited.
